Want to see SEED full AI Analyst Report?
SEED Stock Chart & Stats
$1.00
-$0.01(-0.99%)
At close: 4:00 PM EDT
$1.00
-$0.01(-0.99%)
Day’s Range― - ―
52-Week Range$0.66 - $2.12
Previous CloseN/A
Volume1.83K
Average Volume (3M)101.34K
Market Cap
$11.60M
Enterprise Value$14.71M
Total Cash (Recent Filing)$13.37M
Total Debt (Recent Filing)$29.12M
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Jan 11, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.18
Shares Outstanding14,144,586
10 Day Avg. Volume197,961
30 Day Avg. Volume101,339
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-2.76
Price to Sales (P/S)0.71
P/FCF Ratio-1.80
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit6.01
Enterprise Value/Ebitda-0.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cost StructureThe sharp reduction in operating expenses and narrower operating loss show that restructuring is producing measurable financial benefits. If maintained, the leaner cost base can improve operating leverage as commercial activity recovers, helping the company convert future revenue growth into better earnings.
Breeding PipelineA large and expanding breeding pipeline provides Origin with multiple opportunities to develop differentiated corn varieties and replenish its commercial portfolio. Continued R&D and AI-assisted use of germplasm can support product innovation and strengthen the company’s competitive position over several seasons.
Biotech ReadinessThe combination of biosafety credentials, GMO production authorization and restored processing capacity improves commercial readiness for biotechnology products. These capabilities can support future trait monetization and seed sales, while the consortium and gene-editing tools broaden potential routes to commercialization.
Bears Say
Revenue ContractionThe substantial revenue decline indicates that the commercial rebuild has not yet replaced lost external seed tolling activity with enough new product sales. Persistent top-line weakness would limit operating leverage, reduce internal funding capacity and make the recovery plan more dependent on successful future adoption.
Balance Sheet StressPersistently negative equity and higher debt leave Origin with limited financial flexibility and a more fragile capital structure. The combination can increase refinancing and dilution risk, constrain investment choices and make it harder for the company to absorb continued operating losses or slower commercialization.
Regulatory DependenceA meaningful portion of the company’s potential upside depends on regulatory decisions outside management’s control. Uncertain approval timing can delay product launches, revenue recognition and returns on biotechnology investment, making the commercial recovery less predictable over the next several quarters.
Origin Agritech News
SEED FAQ
What was Origin Agritech Limited’s price range in the past 12 months?
Origin Agritech Limited lowest stock price was $0.66 and its highest was $2.12 in the past 12 months.
What is Origin Agritech Limited’s market cap?
Origin Agritech Limited’s market cap is $11.60M.
When is Origin Agritech Limited’s upcoming earnings report date?
Origin Agritech Limited’s upcoming earnings report date is Jan 11, 2027 which is in 78 days.
How were Origin Agritech Limited’s earnings last quarter?
Origin Agritech Limited released its earnings results on May 21, 2026. The company reported -$0.172 earnings per share for the quarter.
Is Origin Agritech Limited overvalued?
According to Wall Street analysts Origin Agritech Limited’s price is currently Overvalued.
Does Origin Agritech Limited pay dividends?
Origin Agritech Limited does not currently pay dividends.
What is Origin Agritech Limited’s EPS estimate?
Origin Agritech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Agritech Limited have?
Origin Agritech Limited has 14,144,586 shares outstanding.
What happened to Origin Agritech Limited’s price movement after its last earnings report?
Origin Agritech Limited reported an EPS of -$0.172 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Origin Agritech Limited?
Currently, no hedge funds are holding shares in SEED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Origin Agritech Limited
Established in 1997 and headquartered in Beijing, China, Origin Agritech Limited is a Chinese firm operating in two primary areas: agricultural biotechnology and an e-commerce platform. Its biotechnology segment focuses on the genetic enhancement and breeding of crop seeds, encompassing the development, production, and distribution of hybrid crop varieties and associated seed technologies. The firm also manages an e-commerce platform that caters to farmers across China, offering a diverse array of goods via online and mobile channels. This selection includes agricultural seeds like corn, rice, and vegetables, along with essential farming inputs such as fertilizers and agricultural chemicals. Additionally, the platform provides food, household items, and other consumer products. Origin Agritech maintains collaboration agreements with esteemed institutions such as the Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University.
Technical Analysis
American Vanguard
―
Arcadia Biosciences
―
BioHarvest Sciences
―
Bioceres Crop Solutions
―
―
Ownership Overview
―
Insiders
0.06% Mutual Funds
0.15% Other Institutional Investors
99.79% Public Companies and
Individual Investors